Seal Rock Therapeutics to Present SRT-015 Data at Liver Meeting
The company says preclinical studies showed 100% survival and sustained bile flow in an experimental model of bi
The company says preclinical studies showed 100% survival and sustained bile flow in an experimental model of bi